Facebook
Twitter
Telegram
Report an ErrorQualigen Therapeutics Financial Statements 2011-2024 | QLGN
Annual Financial Statements Qualigen Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.84 M | 1.94 M | 102 M | 44.4 M | 3.24 M | 7.2 M | 29.8 M | 4.04 M | - | - | - | - |
Shares |
3.84 M | 2.93 M | 12.5 M | 8.75 M | 212 K | 88.6 K | 36 K | 11.8 K | - | - | - | - |
Historical Prices |
1 | 0.66 | 3.29 | 17.2 | 15.8 | 67.2 | 640 | 362 | - | - | - | - |
Net Income |
-18.6 M | -17.9 M | -1.79 M | -10.1 M | -16.9 M | -7.86 M | -18.4 M | -8.79 M | - | - | - | - |
Revenue |
4.98 M | 5.65 M | 5.56 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | 1.58 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-22.2 M | -22.7 M | -1.5 M | -10.8 M | -17.9 M | -7.9 M | -18.4 M | -8.91 M | -2.28 M | - | - | - |
Interest Expense |
1.12 K | 5.45 K | 283 K | - | - | - | - | - | 10 K | - | - | - |
EBITDA |
-22 M | -22.5 M | -1.29 M | -10.8 M | -17 M | -7.9 M | -18.4 M | -8.91 M | - | - | - | - |
Operating Expenses |
27.2 M | 28.3 M | 3.08 M | 10.8 M | 17 M | 7.9 M | 18.4 M | 8.91 M | - | - | - | - |
General and Administrative Expenses |
10.8 M | 11.7 M | 1.51 M | 4.57 M | 5.43 M | 4.78 M | 4.88 M | 6.4 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Qualigen Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
5.05 M | 5.05 M | 4.96 M | 4.21 M | 3.94 M | 3.67 M | 3.53 M | 35.3 M | 29 M | 28.9 M | 28.2 M | 27.3 M | 19.8 M | 19.8 M | 8.75 M | 19.1 M | 5.6 M | 5.6 M | 8.06 M | 6.04 M | 5.37 M | 5.06 M | 4.94 M | 4.94 M | 14.8 M | 1.4 M | 1.16 M | 11.6 M | 8.59 M | 8.58 M | 8.58 M | 8.58 M | 7.79 M | 552 K | 465 K | 465 K | 451 K | 456 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-3.7 M | -3.46 M | -4.11 M | - | -4.06 M | -4.12 M | -4.32 M | - | -3.04 M | -5.4 M | -5.24 M | - | -8.11 M | -8.11 M | -18.6 M | - | -356 K | -595 K | -4.71 M | - | -4.65 M | -3.58 M | -2.01 M | - | -2.01 M | -1.96 M | -1.67 M | - | -3.53 M | -4.14 M | -3.13 M | - | -3.08 M | -2.1 M | -1.39 M | - | -266 K | -391 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | 1.63 M | 1.61 M | - | 1.44 M | 1.43 M | 722 K | - | 1.16 M | 1.12 M | 1.9 M | - | 838 K | 838 K | 904 K | - | 1.2 M | 1.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | 91 K | 72 K | 39 K | - | 29 K | 28 K | 30 K | - | 32 K | 26 K | 355 K | - | - | 317 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.78 M | -3.55 M | -3.69 M | - | -3.47 M | -4.14 M | -5.01 M | - | -4.81 M | -7.39 M | -5.81 M | - | -3.72 M | -3.72 M | -2.57 M | - | -290 K | -525 K | -4.78 M | - | -4.66 M | -3.61 M | -2.04 M | - | -2.01 M | -1.97 M | -1.68 M | - | -3.54 M | -4.16 M | -3.15 M | - | -3.11 M | -2.1 M | -1.4 M | - | -254 K | -386 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
33.5 K | 5.68 K | 4.88 K | - | 4.63 K | -376 | 36 | - | 702 | 2.35 K | 542 | - | 715 | 58.1 K | -250 K | - | 65.5 K | 70 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -3.53 M | -3.63 M | - | -3.37 M | -4.12 M | -4.98 M | - | -4.73 M | -7.34 M | -5.79 M | - | -3.61 M | -3.66 M | -2.52 M | - | -273 K | -468 K | -4.78 M | - | -4.66 M | -3.6 M | -2.04 M | - | -2.01 M | -1.97 M | -1.68 M | - | -3.54 M | -4.15 M | -3.15 M | - | -3.11 M | -2.1 M | -1.4 M | - | -251 K | -384 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.78 M | 5.18 M | 5.3 M | - | 3.47 M | 5.57 M | 5.73 M | - | 5.96 M | 8.51 M | 7.71 M | - | 4.56 M | 4.56 M | 3.47 M | - | 1.49 M | 2.04 M | 4.78 M | - | 4.66 M | 3.61 M | 2.04 M | - | 2.01 M | 1.97 M | 1.68 M | - | 3.54 M | 4.16 M | 3.15 M | - | 3.11 M | 2.1 M | 1.4 M | - | 254 K | 386 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.34 M | 2.67 M | 1.71 M | - | 2.54 M | 2.66 M | 2.9 M | - | 2.76 M | 2.95 M | 2.87 M | - | 2.66 M | 2.66 M | 1.98 M | - | 203 K | 269 K | 1.15 M | - | 1.14 M | 1.69 M | 1.13 M | - | 1.05 M | 1.14 M | 1.17 M | - | 1.09 M | 1.21 M | 1.24 M | - | 1.56 M | 2 M | 1.3 M | - | 166 K | 352 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency